Copyright © 2001 by the European Society of Cardiology.
Acute and mid-term combined hormone replacement therapy improves endothelial function in post-menopausal women with angina and angiographically normal coronary arteries
a Cardiovascular Institute, University of Barcelona, Spain
b Obstetrics and Gynaecology Institute, University of Barcelona, Spain
c Laboratory of Hemostasis, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Spain
revised February 5, 2001; accepted February 7, 2001
Abstract
Aims and background Coronary endothelial dysfunction improves after acute oestradiol treatment in women with angina and normal coronary angiograms. We sought to analyse whether this effect is also seen in the peripheral circulation and whether it is sustained after a mid-term period of treatment.
Methods We studied 20 women with angina, signs suggestive of myocardial ischaemia and normal coronary angiograms. In five of them, coronary and peripheral endothelial functions were studied at baseline. Brachial artery flow-mediated dilation was reanalysed after 24h of transdermal oestradiol treatment. In the other 15 women, brachial artery vasoreactivity was studied at baseline and after a 6-week period of treatment with transdermal oestradiol and medroxyprogesterone (HRT) or placebo in a double-blinded crossover fashion.
Results An abnormal coronary artery response to acetylcholine was observed in all women as well as impaired brachial flow-mediated dilation. Brachial flow-mediated dilation significantly increased after 24h of oestradiol treatment (4·8±0·8% vs 0·06±0·6%,P <0·001). Peripheral flow-mediated dilation also increased after a 6-week period of HRT compared with baseline (4·1±3% vs 0·4±1%, P<0·01) and placebo treatment (4·1±3% vs 0·6±1·7%,P <0·01).
Conclusion Impaired endothelium-dependent vasodilation exists both at the coronary and peripheral circulation in post-menopausal women with angina and normal coronary angiograms. Flow-mediated dilation improves in these women after short and mid-term therapy with transdermal oestradiol irrespective of concomitant progesterone use.
Key Words: Endothelial function, oestradiol, hormone replacement therapy, syndrome X
f1 Correspondence: Magda Heras, MD, PhD, Cardiovascular Institute, Hospital Clínic, Villarroel 136, 08036 Barcelona, Spain.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. R. Meendering, B. N. Torgrimson, N. P. Miller, P. F. Kaplan, and C. T. Minson Estrogen, medroxyprogesterone acetate, endothelial function, and biomarkers of cardiovascular risk in young women Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1630 - H1637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, K. Fox, M. A. A. Garcia, D. Ardissino, P. Buszman, P. G. Camici, F. Crea, C. Daly, G. De Backer, P. Hjemdahl, et al. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology Eur. Heart J., June 1, 2006; 27(11): 1341 - 1381. [Full Text] [PDF]
|
|
|
|
|
|
G.M.C. Rosano, M. Fini, and G. Mercuro Hormone replacement therapy in women with angina with normal coronary arteriograms. Pathogenetic or symptomatic therapy? Eur. Heart J., November 2, 2001; 22(22): 2051 - 2054. [PDF]
|
|